These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28593442)

  • 1. Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease.
    Lee J; Hwang YJ; Kim Y; Lee MY; Hyeon SJ; Lee S; Kim DH; Jang SJ; Im H; Min SJ; Choo H; Pae AN; Kim DJ; Cho KS; Kowall NW; Ryu H
    Acta Neuropathol; 2017 Nov; 134(5):729-748. PubMed ID: 28593442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model.
    Hwang YJ; Hyeon SJ; Kim Y; Lim S; Lee MY; Kim J; Londhe AM; Gotina L; Kim Y; Pae AN; Cho YS; Seong J; Seo H; Kim YK; Choo H; Ryu H; Min SJ
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):856-868. PubMed ID: 33771089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
    Ryu H; Lee J; Hagerty SW; Soh BY; McAlpin SE; Cormier KA; Smith KM; Ferrante RJ
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19176-81. PubMed ID: 17142323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
    Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
    J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease.
    Lee J; Hwang YJ; Shin JY; Lee WC; Wie J; Kim KY; Lee MY; Hwang D; Ratan RR; Pae AN; Kowall NW; So I; Kim JI; Ryu H
    Acta Neuropathol; 2013 May; 125(5):727-39. PubMed ID: 23455440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations.
    Irmak D; Fatima A; Gutiérrez-Garcia R; Rinschen MM; Wagle P; Altmüller J; Arrigoni L; Hummel B; Klein C; Frese CK; Sawarkar R; Rada-Iglesias A; Vilchez D
    Hum Mol Genet; 2018 Dec; 27(23):4117-4134. PubMed ID: 30452683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of Huntington's Disease.
    Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
    Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington's disease.
    Lee J; Hong YK; Jeon GS; Hwang YJ; Kim KY; Seong KH; Jung MK; Picketts DJ; Kowall NW; Cho KS; Ryu H
    Cell Death Differ; 2012 Jul; 19(7):1109-16. PubMed ID: 22240898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of nucleosome dynamics in Huntington's disease.
    Stack EC; Del Signore SJ; Luthi-Carter R; Soh BY; Goldstein DR; Matson S; Goodrich S; Markey AL; Cormier K; Hagerty SW; Smith K; Ryu H; Ferrante RJ
    Hum Mol Genet; 2007 May; 16(10):1164-75. PubMed ID: 17403718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease.
    Ferrante RJ; Ryu H; Kubilus JK; D'Mello S; Sugars KL; Lee J; Lu P; Smith K; Browne S; Beal MF; Kristal BS; Stavrovskaya IG; Hewett S; Rubinsztein DC; Langley B; Ratan RR
    J Neurosci; 2004 Nov; 24(46):10335-42. PubMed ID: 15548647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription.
    Hwang YJ; Han D; Kim KY; Min SJ; Kowall NW; Yang L; Lee J; Kim Y; Ryu H
    Nucleic Acids Res; 2014 Feb; 42(3):1628-43. PubMed ID: 24234436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
    Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
    J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model.
    Baronchelli S; La Spada A; Ntai A; Barbieri A; Conforti P; Jotti GS; Redaelli S; Bentivegna A; De Blasio P; Biunno I
    Mol Cell Neurosci; 2017 Jul; 82():46-57. PubMed ID: 28476540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.
    Song W; Zsindely N; Faragó A; Marsh JL; Bodai L
    Hum Mol Genet; 2018 Feb; 27(4):649-666. PubMed ID: 29281014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease.
    Dong X; Tsuji J; Labadorf A; Roussos P; Chen JF; Myers RH; Akbarian S; Weng Z
    PLoS One; 2015; 10(12):e0144398. PubMed ID: 26636336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETDB1/NSD-dependent H3K9me3/H3K36me3 dual heterochromatin maintains gene expression profiles by bookmarking poised enhancers.
    Barral A; Pozo G; Ducrot L; Papadopoulos GL; Sauzet S; Oldfield AJ; Cavalli G; Déjardin J
    Mol Cell; 2022 Feb; 82(4):816-832.e12. PubMed ID: 35081363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Drosophila Huntington's disease gene ortholog dhtt influences chromatin regulation during development.
    Dietz KN; Di Stefano L; Maher RC; Zhu H; Macdonald ME; Gusella JF; Walker JA
    Hum Mol Genet; 2015 Jan; 24(2):330-45. PubMed ID: 25168387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
    Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
    Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.